Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Key Takeaways
Introduction
For decades, the clinical approach to periodontal disease has followed a fundamentally adversarial logic: identify the harmful bacteria, remove them mechanically, and where necessary suppress them chemically. Scaling and root planing, chlorhexidine, systemic and local antibiotics — all are forms of microbial warfare, aimed at reducing the bacterial load in the periodontal pocket to a level the host immune system can manage.
It is an approach that works — but not perfectly, not permanently, and increasingly not without cost. Antibiotic resistance is a growing concern in periodontal practice as elsewhere, and the blunt instrument of broad-spectrum antimicrobials disrupts the beneficial oral microbiome alongside the harmful one. The mouth harbours over 700 bacterial species, the vast majority of which are either commensal or actively beneficial. Killing them all to reach the pathogens carries consequences.
A new study published in npj Biofilms and Microbiomes in late 2025 proposes a fundamentally different strategy — one that does not kill bacteria at all, but instead disrupts how they talk to each other. The implications, if the approach translates from laboratory to clinic, could reshape periodontal prevention and treatment.
The Ecosystem Model: Plaque as a Forest
To understand the new approach, it helps to understand how dental plaque develops — and why the conventional model of simply removing it is insufficient for many patients.
“Dental plaque develops in a sequence, much like a forest ecosystem,” said Mikael Elias, associate professor in the College of Biological Sciences at the University of Minnesota and senior author of the study. “Pioneer species like Streptococcus and Actinomyces are the initial settlers in simple communities — they’re generally harmless and associated with good oral health. Increasingly diverse late colonisers include the ‘red complex’ bacteria like Porphyromonas gingivalis, which are strongly linked to periodontal disease. By disrupting the chemical signals bacteria use to communicate, one could manipulate the plaque community to remain or return to its health-associated stage.”
This ecological framing is increasingly central to how microbiologists think about periodontitis. The oral microbiome comprises over 700 distinct species, forming complex biofilms essential for maintaining oral and systemic health. When microbial homeostasis in the periodontium is disrupted, pathogens within the biofilm can cause periodontitis and peri-implantitis, inducing host immune responses. The disease is not simply the presence of bad bacteria — it is the displacement of a healthy community by a pathogenic one.
The question is whether that displacement can be prevented, or reversed, without destroying the community entirely.
Quorum Sensing: How Bacteria Talk
The mechanism at the heart of the Minnesota study is quorum sensing — a system of chemical communication that bacteria use to coordinate their behaviour based on population density.
Bacterial communication — known as quorum sensing — allows microbes to detect their population density and coordinate community behaviour. In dental plaque, which contains hundreds of microbial species, AHL signals can be produced in oxygen-rich zones above the gumline and perceived by bacteria in oxygen-poor niches below the gumline.
Think of it as a census system. Individual bacteria produce and release small signalling molecules — in this case N-acyl homoserine lactones (AHLs). As the bacterial population grows, AHL concentrations rise. When they reach a threshold, the bacteria collectively detect that they are numerous enough to act — and switch on behaviours that would be ineffective at low population densities: biofilm formation, virulence factor production, and the emergence of the late-stage pathogenic colonisers associated with periodontal disease.
Gram-positive and Gram-negative bacteria within oral biofilms exchange information via quorum sensing, a mechanism through which bacteria secrete diffusible signalling molecules. This process coordinates a range of physiological and pathological activities for the microbiome, including biofilm formation and growth, adapting to environmental changes in the oral cavity, competing for superiority against potential rivals, and expressing virulence factors that enable pathogens to cause disease.
In short: quorum sensing is the trigger that allows a healthy early-stage plaque community to tip into a disease-causing one. Disrupt the signal, and the tip may never happen.
The Study: Silencing the Signal
The Minnesota team, led by Elias and colleagues from the School of Dentistry, investigated whether interfering with AHL signalling could alter the composition of oral biofilm communities — and whether it could do so selectively, favouring health-associated species over pathogenic ones.
In laboratory models, the team used specialised lactonase enzymes to remove AHL signals, effectively “quenching” quorum sensing. This disruption was associated with an increased relative abundance of bacteria tied to oral health. Conversely, adding external AHLs under low-oxygen conditions tended to promote late colonisers associated with disease.
The result is a proof-of-concept with significant implications. Eliminating AHL signals using specialised enzymes called lactonases led to an increase in bacterial species associated with good oral health. These results indicate that carefully chosen enzymes might be used to reshape dental plaque communities and help maintain a healthy balance of microbes.
Crucially, the approach is targeted rather than indiscriminate. By degrading the AHL signals that coordinate the emergence of late-stage pathogens, the lactonase treatment allows the beneficial early colonisers to maintain their dominance — without the broad-spectrum disruption of a conventional antimicrobial. By allowing bacteria that support healthy oral functions alone to keep communicating, they can reproduce in the mouth and foster a healthier microbiome in the process.
Why This Matters: The Antibiotic Resistance Problem
The antimicrobial resistance context is central to why this approach is generating significant interest beyond the immediate field of periodontology.
Since antimicrobial resistance is rising, this new method of disrupting microbial conversations may be a significant advancement in upholding oral health. In periodontal practice, the use of systemic antibiotics — metronidazole, amoxicillin, doxycycline — as adjuncts to mechanical therapy is well evidenced, but carries the same resistance implications as antibiotic use anywhere in medicine. Local delivery systems reduce systemic exposure but do not eliminate the selective pressure on the oral microbiome.
A quorum-quenching strategy does not rely on killing bacteria at all. It does not select for resistant mutants in the way that a bactericidal agent does. And because it operates on a signalling system rather than a core bacterial function, the evolutionary pressure to develop resistance may be fundamentally lower — though this remains to be formally tested.
The Broader Landscape: Microbiome-Based Therapies Converging
The quorum-quenching approach is part of a broader shift in how the research community is thinking about periodontal microbiology — away from eradication and toward ecosystem management.
Several other approaches are converging on the same goal from different directions. Emerging microbiome-based therapies, comprising probiotics, postbiotics, predatory bacteria, and bacteriophages, offer promising adjuncts or alternatives to conventional periodontal treatment by targeting the pathogenic microbial consortia such as the red complex while preserving microbial diversity.
Bacteriophages — viruses that target specific bacterial species — offer perhaps the most precise targeting available, with the capacity to eliminate a single pathogen from a complex community without disturbing others. Novel lytic bacteriophages have been shown to exhibit specificity in targeting and lysing Fusobacterium nucleatum, resulting in a significant reduction of its abundance within the periodontal microbiome, without causing substantial damage to beneficial oral microbial communities — enabling more effective maintenance and restoration of the healthy balance within the periodontal microecosystem.
Probiotics offer a complementary approach: rather than targeting pathogens directly, they seek to reinforce the beneficial microbial community, making it more resilient to displacement by pathogenic species. The evidence base for probiotics in periodontal therapy is accumulating, particularly for Lactobacillus reuteri and Lactobacillus rhamnosus, though it remains at an early stage of clinical translation.
What Remains to Be Done
The Minnesota study is significant as a proof of concept, but the path to clinical application is a long one. The team’s own next steps reflect this: scientists aim to study the communication system between bacteria in different parts of the mouth through patients with varying stages of periodontal disease in order to understand and control the bacteria population more precisely.
Several important questions remain. Can lactonase-based treatments be delivered effectively to the subgingival environment, where the most clinically significant bacterial communities reside? Do they maintain their activity in the complex biochemical environment of the periodontal pocket? What is their stability, safety profile, and shelf-life in a clinically usable formulation? And critically — does shifting the community composition in laboratory models translate into meaningful clinical outcomes in patients with established periodontitis?
Current periodontal treatments primarily focus on removal of subgingival dental plaque in periodontal pockets. However, the presence of biofilms within gingival tissues challenges the conventional paradigm and highlights the need for therapeutic delivery strategies capable of penetrating gingival tissue and disrupting intra-tissue microbial communities, rather than focusing solely on surface-level biofilm removal.
These are significant challenges — but they are engineering and clinical translation problems, not fundamental biological barriers. The mechanism works. Whether it can be packaged into a viable clinical intervention is the next question.
Implications for Practice
For the practising periodontist, the immediate clinical implications of this research are limited — lactonase-based treatments are not yet available, and the journey to regulatory approval and clinical adoption will take years. But the conceptual shift is worth internalising now, because it has implications for how practitioners communicate with patients and think about long-term maintenance.
The microbiome model of periodontal disease — in which the goal of treatment is not to sterilise the mouth but to restore a healthy microbial balance — is increasingly the scientific consensus. Strategies focusing on controlling pathogenic bacteria, modulating immune responses, and promoting tissue regeneration are key to restoring periodontal stability — alongside interventions targeting the microbiome to enhance treatment outcomes.
For patients, this framing is also more empowering. The message is not that the mouth is under permanent threat from bacteria that must be constantly suppressed — it is that a healthy oral microbiome is an asset worth maintaining, and that the goal of oral hygiene and professional care is to support that ecosystem rather than simply assault it.
Conclusion
The University of Minnesota’s quorum-quenching research represents one of the most conceptually interesting developments in periodontal microbiology in recent years. It does not offer an immediate clinical solution — but it points toward a future in which periodontal prevention involves not antimicrobial agents, but precision microbiome management: targeted, resistance-sparing, and aligned with the biology of oral health rather than simply opposed to the biology of disease.
The team believes this strategy could eventually lead to therapies for other parts of the body where imbalances in the microbiome are linked to illness and certain forms of cancer — a reminder that the mouth, as ever, is not just a mouth. What is learned here will travel far beyond the dental chair.
Sources: Sikdar R, Beauclaire MV, Herzberg MC, Lima BP, Elias MH. N-acyl homoserine lactone signalling modulates bacterial community associated with human dental plaque. npj Biofilms and Microbiomes. 2025;11(1). DOI: 10.1038/s41522-025-00846-z. Additional references: Frontiers in Cellular and Infection Microbiology (Gangula et al., 2025; Frontiers in Cellular and Infection Microbiology, 2025); Folia Microbiologica, October 2025; Frontiers in Cellular and Infection Microbiology, June 2025 (Zhejiang University).
— periojournal.com
